Conjugated Estrogens-Bazedoxifene Combination Reduces Postmenopausal Bone Loss Conjugated Estrogens-Bazedoxifene Combination Reduces Postmenopausal Bone Loss

The combination of conjugated estrogens with bazedoxifene (CE/BZA) significantly improves bone mineral density (BMD) and bone turnover, according to pooled results from the SMART-1 and SMART-5 trials. < br / > < i > Reuters Health Information < /i >
Source: Medscape Orthopaedics Headlines - Category: Orthopaedics Tags: Rheumatology News Source Type: news